Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Oral Calcitriol in Breast Cancer
NCT01293682Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Nov 2010
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcitriol in breast cancer, sponsored by University of Rochester. Started Nov 2010; status: completed.
02
Drugs
calcitriol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01293682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01293682.